2.62
Schlusskurs vom Vortag:
$2.90
Offen:
$2.9
24-Stunden-Volumen:
593.30K
Relative Volume:
1.37
Marktkapitalisierung:
$36.61M
Einnahmen:
$12,000
Nettoeinkommen (Verlust:
$-48.50M
KGV:
-0.1535
EPS:
-17.0687
Netto-Cashflow:
$-19.78M
1W Leistung:
-13.98%
1M Leistung:
-32.95%
6M Leistung:
-80.39%
1J Leistung:
-83.24%
Incannex Healthcare Inc Stock (IXHL) Company Profile
Firmenname
Incannex Healthcare Inc
Sektor
Telefon
61 409 840 786
Adresse
8 CENTURY CIRCUIT, NORWEST NSW
Compare IXHL vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
IXHL
Incannex Healthcare Inc
|
2.6199 | 40.52M | 12,000 | -48.50M | -19.78M | -17.07 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.20 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
118.24 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
9.935 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.68 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
555.02 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Incannex Healthcare Inc Aktie (IXHL) Neueste Nachrichten
IXHL Should I Buy - Intellectia AI
IXHL Stock Price, Quote & Chart | INCANNEX HEALTHCARE INC (NASDAQ:IXHL) - ChartMill
IXHL SEC FilingsIncannex Healthcare Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Insider Buy: Can Incannex Healthcare Inc benefit from deglobalization2026 Price Targets & Low Drawdown Momentum Ideas - baoquankhu1.vn
$Incannex Healthcare (IXHL.US)$ - Moomoo
Finally - Moomoo
Incannex reactivates share repurchase program, cites ‘significant disconnect’ between its market cap and financial strength - MSN
IXHL Stock Gains As Incannex Reactivates Share Repurchase Program - Stocktwits
Incannex resumes share buyback after period of inactivity By Investing.com - Investing.com Australia
Buyout Rumor: Can Incannex Healthcare Inc sustain earnings growthIPO Watch & Free High Return Stock Watch Alerts - baoquankhu1.vn
Incannex Reactivates Share Buyback, Signaling Valuation Confidence - TipRanks
Incannex resumes share buyback after period of inactivity - Investing.com
Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position - The Manila Times
Incannex reactivates share repurchase program, underscoring confidence in valuation and strategic position - marketscreener.com
Incannex Reactivates Share Repurchase Program After Financing, $75M Cash and No Debt - TradingView
Incannex Healthcare (NASDAQ: IXHL) restarts share buyback, holding $75M cash and no debt - Stock Titan
Two trading days in, Incannex revives stock buybacks with $18.5M left - Stock Titan
Growth Value: Is Incannex Healthcare Inc a top pick in the sector2026 Trading Volume Trends & High Accuracy Investment Entry Signals - baoquankhu1.vn
Incannex Deepens Sleep Apnea Focus With AASM Partnership - TipRanks
IXHL Surges 12% With No Catalyst and Weak Volume - Bitget
Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research - bitget.com
Incannex (Nasdaq: IXHL) backs sleep apnea research as IHL-42X advances - stocktitan.net
Sleep apnea affects millions; Incannex funds junior research grant - Stock Titan
Incannex says it holds $75 million in cash with zero debt after financing - MSN
Incannex Healthcare Company Profile & Introduction - Moomoo
IXHL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Incannex reports $75M cash position with no debt after financing By Investing.com - Investing.com South Africa
Incannex reports $75M cash position with no debt after financing - Investing.com Australia
Incannex Highlights $75 Million Cash, No Debt, and Advances IHL-42X and PSX-001 Clinical Programs - Minichart
Incannex approves 1-for-30 reverse stock split to regain Nasdaq compliance - MSN
Incannex Healthcare Inc. (IXHL) implements 1-for-30 reverse split effective February 26 - MSN
Incannex Healthcare Strengthens Cash Position, Highlights Clinical Pipeline - TipRanks
Incannex Highlights $75M Cash, No Debt as It Funds DReAMzz Phase 2 and Advances IHL-42X - TradingView
Incannex Highlights Strong Balance Sheet with Approximately $75 Million in Cash and No Debt as Company Advances IHL-42X Development - The Manila Times
Incannex (Nasdaq: IXHL) highlights $75M cash, no debt and advancing trials - Stock Titan
Market values Incannex at $46M despite $75M in cash - Stock Titan
Incannex regains Nasdaq compliance with minimum bid price By Investing.com - Investing.com South Africa
Incannex Healthcare Regains Nasdaq Compliance and Advances Clinical Pipeline with Strong Cash Position - Minichart
Incannex regains Nasdaq compliance with minimum bid price - Investing.com
Incannex regains compliance with Nasdaq minimum bid price requirement - MarketScreener
Incannex Regains Nasdaq Compliance, Strengthening Pipeline Progress - TipRanks
Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement - The Manila Times
Incannex Healthcare (NASDAQ: IXHL) restores Nasdaq bid price compliance, highlights $75M cash - Stock Titan
Biotech Incannex clears Nasdaq listing hurdle, holds $75M cash and no debt - Stock Titan
Finanzdaten der Incannex Healthcare Inc-Aktie (IXHL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):